Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Jonathan Mark Fussey

Showing results (1-10 of 6) with videos related to

Pageof 1
Sort By:
Current Opinion in Otolaryngology & Head and Neck Surgery|February 4, 2020
Controversies in the surgical management of sporadic medullary thyroid carcinomaJonathan Mark Fussey, Patrick J Bradley, Joel A Smith
Head & Neck|September 30, 2017
Thyroid-stimulating hormone suppression therapy for differentiated thyroid cancer: The role for a combined T3/T4 approachJonathan Mark Fussey, Habib Khan, Farhan Ahsan, et al.
International Journal of Pediatric Otorhinolaryngology|July 1, 2018
Clinical outcomes following Cochlear™ BIA300 bone anchored hearing aid implantation in childrenJonathan Mark Fussey, Emilie Harterink, Jaspreet Gill, et al.
Clinical Endocrinology|July 14, 2019
The role of molecular genetics in the clinical management of sporadic medullary thyroid carcinoma: A systematic reviewJonathan Mark Fussey, Bijay Vaidya, Dae Kim, et al.
The Journal of Clinical Endocrinology and Metabolism|May 12, 2020
Does Obesity Cause Thyroid Cancer? A Mendelian Randomization StudyJonathan Mark Fussey, Robin N Beaumont, Andrew R Wood, et al.
Clinical Endocrinology|December 19, 2020
Diagnostic RET genetic testing in 1,058 index patients: A UK centre perspectiveJonathan Mark Fussey, Joel Anthony Smith, Ruth Cleaver, et al.
Pageof 1

Showing results (1-10 of 6) with videos related to

Sort By:
Pageof 1
Current Opinion in Otolaryngology & Head and Neck Surgery|February 4, 2020
Controversies in the surgical management of sporadic medullary thyroid carcinomaJonathan Mark Fussey, Patrick J Bradley, Joel A Smith
Head & Neck|September 30, 2017
Thyroid-stimulating hormone suppression therapy for differentiated thyroid cancer: The role for a combined T3/T4 approachJonathan Mark Fussey, Habib Khan, Farhan Ahsan, et al.
International Journal of Pediatric Otorhinolaryngology|July 1, 2018
Clinical outcomes following Cochlear™ BIA300 bone anchored hearing aid implantation in childrenJonathan Mark Fussey, Emilie Harterink, Jaspreet Gill, et al.
Clinical Endocrinology|July 14, 2019
The role of molecular genetics in the clinical management of sporadic medullary thyroid carcinoma: A systematic reviewJonathan Mark Fussey, Bijay Vaidya, Dae Kim, et al.
The Journal of Clinical Endocrinology and Metabolism|May 12, 2020
Does Obesity Cause Thyroid Cancer? A Mendelian Randomization StudyJonathan Mark Fussey, Robin N Beaumont, Andrew R Wood, et al.
Clinical Endocrinology|December 19, 2020
Diagnostic RET genetic testing in 1,058 index patients: A UK centre perspectiveJonathan Mark Fussey, Joel Anthony Smith, Ruth Cleaver, et al.
Pageof 1